Livestock Monitoring Market Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2020 - 2026

 The global livestock monitoring market expected to reach USD 10.93 billion by 2027. according to a new study by Polaris Market Research. The report “Livestock Monitoring Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Cattle, Poultry, Swine, Equine); By Component (Hardware, Software, Services); By Application (Milk Harvesting, Breeding Management, Feeding Management, Animal Health Monitoring & Comfort, Heat Stress, Behavior Monitoring), By Regions; Segment Forecast, 2020 – 2027”

 

The global livestock monitoring market is driven by the growing need to increase farm productivity, innovations in cattle feed rich in protein, reducing supply chain hiccups, and technological advancements in real-time cattle monitoring. Technology providers attempt to reduce the time-consuming task of cattle monitoring with automated systems at reasonable subscription-based charges. Corporatization of cattle farms across the developed economies also favoring the adoption of such services.

 

The global livestock monitoring market is fragmented based on animal type, component, application, and region. In terms of animal type, the market is segmented into cattle, poultry, swine, equine, and others. The component segment is further divided into hardware, software, and services. The application segment is further divided into milk harvesting, breeding management, feeding management, animal health monitoring & comfort, heat stress, behavior monitoring, and others.

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/livestock-monitoring-market/request-for-sample

 

 

Segment Highlights

• The cattle market segment accounted for the largest revenue share in 2019 owing to the presence of a high proportion of cattle producers in the form of meat and milk. The segment held over 45% of the market share.

 

• Based on application, the feeding management segment is projected to constitute most of the market in 2027. Innovations in cattle feed to increase productivity, and the emergence of well-maintained cattle farms are primarily responsible for such growth.

 

• North American region is dominating the global livestock monitoring market, holding almost one-third of the market share throughout the forecast period. This high share is due to positive intention to increase farm productivity, rise in per capita consumption, and cost reductions in service offerings with continuously rising competitive rivalry.

 

• The players including Lely International N.V, GEA Farm Technologies, BouMatic, LLC together held a significant market share of the global market in the year 2019.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/livestock-monitoring-market/speak-to-analyst

List of Key Players of Livestock Monitoring Market

• Lely International NV
• GEA Farm Technologies
• BouMatic, LLC
• Antelliq Corporation
• Gallagher Group Limited
• DeLaval
• Afimilk Ltd.
• HID Global Corporation
• Dairymaster Ltd.
• Communications Group Lethbridge Ltd.
• Others

 

Polaris Market Research has segmented the Livestock Monitoring Market report on the basis of animal type, component, application, and region:

 

Livestock Monitoring Market, Animal Type Outlook (Revenue – USD Million, 2016 – 2027)

• Cattle
• Poultry
• Swine
• Equine
• Others

Livestock Monitoring Market, Component Outlook (Revenue – USD Million, 2016 – 2027)

• Hardware
  • Sensors
  • GPS
  • Others
• Software
  • On-cloud
  • On-premise
• Services
  • Integration & development
  • Maintenance & Support
  • Others

Livestock Monitoring Market, Application Outlook (Revenue – USD Million, 2016 – 2027)

• Milk Harvesting
• Breeding Management
• Feeding Management
• Animal Health Monitoring & Comfort
• Heat stress
• Behavior monitoring
• Others

Read More : https://www.medgadget.com/2021/02/livestock-monitoring-market-size-is-projected-to-reach-10-93-billion-by-2027-cagr-15-7-polaris-market-research.html

Synoptophore Market Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2020 - 2026

 The global synoptophore market size is predicted to reach USD 293.8 million by 2027 according to a new study by Polaris Market Research. The report “Synoptophore Market Share, Size, Trends, Industry Analysis Report, By Application (Diagnostics and Therapeutics); By Product (Manual and Automated); By End User (Hospitals, Clinics, Others); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The synoptophore market is expected to witness substantial growth as the instrument is the primary and major choice in several eye imbalance ailments such as squint and benefits associated with synoptophore over other invasive techniques. For instance, as per the American Association for Pediatric Ophthalmology and Strabismus, approximately 4 percent of the U.S. population is affected by strabismus.

 

Rising prevalence of strabismus and squint in young and adult population coupled with rising incidence of stroke in adolescents is predicted to be the primary supporting factors for market growth. Moreover, increasing awareness for non-invasive techniques is predicted to propel the growth of the global market.

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/synoptophore-market/request-for-sample

 

 

Furthermore, the additional benefits of synoptophore in several eye defects which includes cyclophoria and retinal correspondence problem is predicted to provide new growth opportunities over the forecast period. The therapeutic use of the device for eccentric fixation and eye related disorders is further predicted to bring productive market growth opportunities.

 

The major players in the market which are involved in product launches, acquisitions, and collaboration in order to build their product portfolio are: Shanghai Link Instrument Co. Ltd., Nanjing Redsun Optical Co., Ltd.; 6 6 VISION-TECH CO., LTD.; Haag-Streit group; Appasamy Associates; Prkamya Visions; Takagi Seiko Co., Ltd.; Gem Optical Instruments Industries.

 

In June 2020, Haag Streit completed the acquisition of Germany-based VRMagic providing simulators for the ophthalmology training. The acquisition is expected to complement Haag Streit training to its eye-care professionals. This will place the company as a major player and would enable to increase its footprint.

 

Do You Have Any Query Or Specific Requirement? Ask To Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/synoptophore-market/speak-to-analyst

  

Polaris Market Research has segmented the synoptophore market report on the basis of product type, application, end use, and region

 

Global Synoptophore Market, By Product (Revenue – USD Million, 2016 – 2027)

• Manual
• Automated

Global Synoptophore Market, By Application (Revenue – USD Million, 2016 – 2027)

• Diagnostics
• Therapeutics

Global Synoptophore Market, By End-Use (Revenue – USD Million, 2016 – 2027)

• Hospitals
• Clinics
• Others

Global Synoptophore Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Read More : ​https://www.medgadget.com/2021/02/synoptophore-market-size-worth-293-8-million-by-2027-exclusive-study-by-polaris-market-research.html​​​

Actigraphy Sensors and PSG Devices Market Competitive Landscape and Outlook Report 2020-2026

 The Global Actigraphy Sensor And PSG Devices Market Size Is Expected To Reach USD 1.65 Billion By 2027 According To A New Study By Polaris Market Research. The Report “Actigraphy Sensor And PSG Devices Market Share, Size, Trends, Industry Analysis Report, By Product Type (Actigraphy Devices; Polysomnography Devices); By Technology (Wireless, USB, GPS), By Distribution Channel (Retail Stores, Online Retail Stores, Pharmacies, Hospitals, Diagnostic Laboratories, Homecare Settings); By Regions; Segment Forecast, 2020 – 2027” Gives A Detailed Insight Into Current Market Dynamics And Provides Analysis On Future Market Growth.

 

Actigraphy And PSG Devices Play An Important Role In Management Of Sleep Disorders. Growing Prevalence Of Sleep Disorders And Alterations In Sleeping Patterns Has Led To Sleep Disorders Ranging From Minor Disturbances To Major Sleep Problems. While Chronic Sleep Disorders Make A Crucial Impact On Person’s Quality Of Life And Health, Management Of These Disorders At An Early Phase Is Quite Essential. As Increasing Number Of Patients Are Seeking Diagnostic Services To Secure Accurate Treatment For Sleep Disorders, The Demand For Actigraphy Sensors And PSG Devices Is Continuously Increasing.

 

Download Sample Copy @ https://Www.Polarismarketresearch.Com/Industry-Analysis/Actigraphy-Sensors-Psg-Devices-Market/Request-For-Sample

 

 

The Market Is Driven By Continuously Increasing Prevalence Of Insomnia, Stressed Lifestyle, Which In Turn Increases The Number Of People With Disturbed Sleep Cycle And Are The Potential Patients For Treatment. Adoption Of These Devices In Diagnostics And Inclusion In Treatment Plan Helps Patients To Achieve Better Patient Outcome. According To The Statistics Published By The Maternal And Child Health Bureau In The U.S., On An Average 60 Million People Suffer With One Or Other Sleeping Pattern Disorder.

 

With Increase In Demand For These Devices Market Participants Such As Fit Bit, Inc. Has Recently Announced The Launch Of New Enterprise Fit Bit Care, Thus Introducing The Launch Of Breakthrough Platform For Enhancing Wellness And Disease Management. This Platform Features Wide Range Of Devices Which Includes But Not Limited To Wearables And Tracking Devices.

 

These Lucrative Market Opportunities Are Leading To Mergers & Acquisitions In The Industry With Resmed, Inc. Acquiring Matrixcare And Garmin Ltd Collaborating With Actigraph To Diversify Their Offerings In This Product Segment. Companies Such As Somnomedics Gmbh, Resmed Inc., Recorders & Medicare Systems Pvt Ltd, Natus Medical, Inc., MEDISANA Gmbh, Koninklijke Philips N V, Garmin Ltd, Fitbit, Inc., Compumedics, Ltd, BMC Medical Co, Aetna Inc., And Activinsights Ltd. Are Some Of The Key Players Operating In The Global Market.

 

Do You Have Any Query Or Specific Requirement? Ask To Our Industry Expert @ Https://Www.Polarismarketresearch.Com/Industry-Analysis/Actigraphy-Sensors-Psg-Devices-Market/Speak-To-Analyst

 

Polaris Market Research Has Segmented The Actigraphy Sensors And PSG Devices Market Report On The Basis Of Product, Technology, And Distribution Channel, And Region

Actigraphy Sensors & PSG Devices Market, Product Outlook (Revenue – USD Million, 2016 – 2027)

• Actigraphy Devices
• Wrist And Handband Devices
• Wearable Devices
• Polysomnography Devices
• Fixed
• Portable

Actigraphy Sensors & PSG Devices Market Technology Outlook (Revenue – USD Million, 2016 – 2027)

• Wireless
• USB
• GPS
• Others

Actigraphy Sensors & PSG Devices Market Distribution Channel Outlook (Revenue – USD Million, 2016 – 2027)

• Retail Stores
• Online Retail Stores
• Pharmacies
• Hospitals
• Diagnostic Laboratories
• Homecare Settings

Actigraphy Sensors & PSG Devices Market Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

 

Read More : Https://Www.Medgadget.Com/2021/02/Actigraphy-Sensor-And-Psg-Devices-Market-Size-Worth-1-65-Billion-By-2027-Exclusive-Study-By-Polaris-Market-Research.Html

 

 

 

Industrial Iot Market Competitive Landscape, Country-Level Breakdown, Segmentation

 According to a new study published by Polaris Market, the global Industrial Internet of Things (IIoT) market is anticipated to reach USD 771.72 billion by 2026. Industries worldwide are looking for new business models to construct a connected enterprise for merging their operational and information departments. This transformation is expected to enhance the overall productivity, operational efficiency, and visibility as well as decrease the complexities of diverse procedures in the industry. The capability of IIoT to decrease costs is the major factor responsible for its high adoption by the industries. Other factors include increased productivity, time-to-market, and process automation. Moreover, decreasing sensors prices has also helped in the reduction of overall costs related to data collection and analytics.

 

The role of IIoT is becoming more prominent in allowing easy access to machines and devices. The adoption of IIoT is further anticipated to escalate globally attributed to increasing innovative efforts by major players such as GE, Cisco and Huawei, as well as increasing initiatives sponsored by governments. 

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/industrial-internet-of-things-iiot-market/request-for-sample

 

For instance, the government of Germany is sponsoring a multi-year strategic initiative ‘Industrie 4.0’, focused on uniting the major participants from public and private sectors along with academia for the creation of an action plan and a broad vision to implement digital technologies in the country’s industrial sector. Furthermore, “Made in China 2025” initiative of the Chinese government is helping the promotion and integration of digital technologies in the industrial sector of China.

 

The market in the Asia Pacific region is projected to grow at the fastest CAGR owing to considerable adoption of IIoT in the countries such as Japan, Taiwan and China. Manufacturing companies across these countries are recognizing the advantages offered by the implementation of IIoT in their production line. China is the dominating country in the Asia Pacific market due to the presence of several manufacturing companies in the region and high adoption of automation technologies.

 

Some of the major players operating in the Industrial IoT include Corning Incorporated, ABB Ltd., Cisco Systems, Inc., General Electric Company, Siemens AG, Rockwell Automation, Inc., IBM Corporation, Microsoft Corporation, ARM Ltd., Intel Corporation, and Kuka AG among others.

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/industrial-internet-of-things-iiot-market/request-for-discount-pricing

C-Reactive Protein Testing Market Competitive Landscape, Country-Level Breakdown, Segmentation

 The global C-reactive protein testing market expected to Reach US$ 1.99 Billion by 2027 according to a new study by Polaris Market Research. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus), By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The key factors responsible for the market growth are recent surge in COVID-19 cases across the globe, market players’ focused approach towards PoC diagnosis, new innovations, and clinical trials in the biomarker discovery. Moreover, the emerging countries, owing to their huge population base, particularly India and China, focusing on rapid tests, which is cost effective and reliable.

 

The market is fragmented based on assay type, detection range, disease area, end-use, and region. In terms of product, the market is segmented into immuno-turbidimetric assay, ELISA, chemiluminescence immunoassay, and others. Based on detection range, the market is further bifurcated into hs-CRP, conventional CRP, and cCRP. Based on disease area, the market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others. The end-use segment is further divided into clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/request-for-sample

 

  

Segment Highlights

• The immuno-turbidimetric segment accounted for the largest revenue share of the market owing to its high specificity and accuracy rate. However, the chemiluminescence assay segment is expected to witness fastest growth over the forecast.
• Based on detection range, the hs-CRP test segment is projected to constitute almost half of the market in 2027. The segment holds majority of share due to its aggressive use in the healthcare industry to check pandemic infections across the regions.
• Cardiovascular diseases accounted for the largest revenue share in 2019 on account of the increasing use of C-reactive protein testing CVD across the regions. In addition, the growing incidences of fatal diseases is expected to drive the market growth.
• North America is accounted for the largest revenue share in 2019 owing to excellent reimbursement setup. However, Asia Pacific is expected to witness fastest revenue growth over the coming years.

 

List of Key Players

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Roche Ltd.
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Abbott Laboratories
• Others

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @

https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/speak-to-analyst

 

Polaris Market Research has segmented the C-Reactive Protein Testing Market  report on the basis of Assay Type, Detection Range, Disease Area, Type and Region

 

C-reactive Protein Testing, Assay Type Outlook (Revenue – USD Million, 2016 – 2027)

• Immuno-turbidimetric Assay
• ELISA
• Clinical
• Nonclinical
• Chemiluminescence Immunoassay
• Others

C-reactive Protein Testing, Detection Range Outlook (Revenue – USD Million, 2016 – 2027)

• hs-CRP
• Conventional CRP
• cCRP

C-reactive Protein Testing, Disease Area Outlook (Revenue – USD Million, 2016 – 2027)

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-reactive Protein Testing, End-Use Outlook (Revenue – USD Million, 2016 – 2027)

• Clinics
• Hospitals
• Laboratories
• Assisted Living Healthcare Facilities
• Home
• Others

C-reactive Protein Testing, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Read More : https://www.medgadget.com/2021/02/c-reactive-protein-testing-market-size-worth-1-99-billion-by-2027-exclusive-study-by-polaris-market-research.html

 

 

 

Neuralgia Treatment Market Competitive Landscape, Country-Level Breakdown, Segmentation

 The global neuralgia treatment market size is predicted to reach USD 2.83 billion by 2027 according to a new study by Polaris Market Research. The report “Neuralgia Treatment Market Size, Share & Trends Analysis Report, By Treatment (Drug Based [Anticonvulsant Medicines, Tricyclic Antidepressants], Surgeries [Balloon Compression, Glycerol Injection, Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression]); By End-Use; By Region, And Segment Forecasts, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia. Furthermore, multiple sclerosis is also one of factors which can cause neuralgia. Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia. This is likely to drive market demand over the forecast period.

 

The potential drug candidates and the expected drug approval is expected to stimulate the global market, with high concentration of pharmaceutical companies engaged in the research & development of novel drugs for neuralgia treatment. For instance, U.S-based drug manufacturer, Biogen Inc. is developing BIIB074 (Vixotrigine) for the treatment of trigeminal neuralgia and is currently in phase II.

 

Download Sample Copy https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/request-for-sample

​

 

Market participants such as Allergan Plc, GlaxoSmithKline Plc., Biogen, Inc., Abbott Laboratories, PixarBio Corporation, Merz Pharma GmbH, Trigemina Inc., Pfizer Inc., Novartis, Lupin, and others. are some of the key players operating in the global market. Biohaven pharmaceuticals has Rimegepant in the phase II clinical trials and it is estimated to be completed by December 2020. The drug is a potent antagonist of the CGRP receptor. The receptor is responsible for neural sensitization and neuropathic pain.

 

In May 2020, CODA Biotherapeutics, Inc. (CODA), the U.S.-based clinical stage pharmaceutical company currently in the process of developing gene therapy based chemogenetic platform announced the collaboration with the Facial Pain Research Foundation (FPRF) to utilize company’s proprietary platform to develop potential therapies and treatment options for the trigeminal neuralgia and other neurological conditions.

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/speak-to-analyst

 

 

Polaris Market Research has segmented the neuralgia treatment market report on the basis of treatment, indication, distribution channel, and region

 

Neuralgia Treatment, By Treatment (Revenue – USD Million, 2016 – 2027)

• Drug Based
  • Anticonvulsant Medicines
    • Carbamazepine
    • Oxcarbazepine
    • Topiramate
    • Gabapentin
    • Pregabalin
    • Clonazepam
    • Phenytoin
    • Lamotrigine
    • Valproic Acid
  • Tricyclic Antidepressants
    • Amitriptyline
    • Nortriptyline
• Surgeries
  • Balloon Compression
  • Glycerol Injection
  • Radiofrequency Thermal Lesioning
  • Stereotactic Radiosurgery
  • Microvascular Decompression

Neuralgia Treatment, By End-Use (Revenue – USD Million, 2016 – 2027)

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Neuralgia Treatment, By Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Read More : https://www.medgadget.com/2021/02/neuralgia-treatment-market-size-worth-2-83-billion-by-2027-exclusive-study-by-polaris-market-research.html